SMURF1: a promising target for colon cancer therapy.
- Published in:
- Protein & Cell, 2025, v. 16, n. 3, p. 157, doi. 10.1093/procel/pwae053
- By:
- Publication type:
- Article
Works matching IS 1674800X AND DT 2025 AND VI 16 AND IP 3
Results: 5
1
2
Endosomal catabolism of phosphatidylinositol 4,5-bisphosphate is fundamental in building resilience against pathogens.
- Published in:
- Protein & Cell, 2025, v. 16, n. 3, p. 161, doi. 10.1093/procel/pwae041
- By:
- Publication type:
- Article
3
A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignancies.
- Published in:
- Protein & Cell, 2025, v. 16, n. 3, p. 227, doi. 10.1093/procel/pwae034
- By:
- Publication type:
- Article
4
IL-24 promotes atopic dermatitis-like inflammation through driving MRSA-induced allergic responses.
- Published in:
- Protein & Cell, 2025, v. 16, n. 3, p. 188, doi. 10.1093/procel/pwae030
- By:
- Publication type:
- Article
5
High-throughput single-microbe RNA sequencing reveals adaptive state heterogeneity and host-phage activity associations in human gut microbiome.
- Published in:
- Protein & Cell, 2025, v. 16, n. 3, p. 211, doi. 10.1093/procel/pwae027
- By:
- Publication type:
- Article